SEC Form 4 · accession 0001213900-26-077631
REGENTIS BIOMATERIALS LTD. · RGNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ehud Geller
Officer — Chief Executive Officer · Director
Period of report
Jul 9, 2026
Accepted (ET)
Jul 13, 2026 · 5:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001912966
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants to purchase ordinary sharesF1,F2 | $0.003 | Jul 9, 2026 | A | 31,250 | A | Feb 23, 2026 | Feb 23, 2029 | Ordinary Shares | 31,250 | 31,250 | D |
Explanation of responses
- F1This warrant was approved by the Board of Directors of the Issuer on February 23, 2026, subject to shareholder approval, which was obtained on July 9, 2026.
- F2The warrants are currently exercisable and have a three year term.